levodopa-carbidopa-entacapone
Selected indexed studies
- Levodopa/carbidopa/entacapone for the treatment of early Parkinson's disease: a meta-analysis. (Neurol Sci, 2020) [PMID:32162166]
- Levodopa/Carbidopa/Entacapone Combination Therapy. (, 2026) [PMID:38261678]
- Levodopa/carbidopa/entacapone (Stalevo). (Neurology, 2004) [PMID:14718682]
_Worker-drafted node — pending editorial review._
Connections
levodopa-carbidopa-entacapone is a side effect of
Sources
- Levodopa/carbidopa/entacapone for the treatment of early Parkinson's disease: a meta-analysis. (2020) pubmed
- Entacapone/levodopa/carbidopa combination tablet: Stalevo. (2003) pubmed
- Levodopa-entacapone-carbidopa intestinal gel infusion in advanced Parkinson's disease: real-world experience and practical guidance. (2022) pubmed
- Levodopa/Carbidopa/Entacapone Combination Therapy. (2026) pubmed
- Levodopa/carbidopa/entacapone (Stalevo). (2004) pubmed
- [Triple combination of levodopa, carbidopa and entacapone by intrajejunal pump in advanced Parkinson's disease]. (2022) pubmed
- Levodopa-Entacapone-Carbidopa Intrajejunal Infusion in Advanced Parkinson's Disease - Interim Analysis of the ELEGANCE Study. (2025) pubmed
- Levodopa/carbidopa/entacapone in Parkinson's disease. (2009) pubmed
- Levodopa-entacapone-carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease. (2025) pubmed
- Real-world considerations regarding the use of the combination of levodopa, carbidopa, and entacapone (Stalevo(®) ) in Parkinson's disease. (2023) pubmed
- Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson's disease: focus on levodopa/carbidopa/entacapone. (2012) pubmed
- Levodopa-Carbidopa-Entacapone Intestinal Gel in Advanced Parkinson Disease: A Multicenter Real-Life Experience. (2024) pubmed
- The device-aided intrajejunal delivery of levodopa-entacapone-carbidopa intestinal gel the treatment of Parkinson's disease: overview of efficacy and safety. (2025) pubmed
- Therapeutic effect of levodopa-carbidopa-entacapone combined with rTMS in Parkinson's disease. (2025) pubmed
- Effects of One-Day Application of Levodopa/Carbidopa/Entacapone versus Levodopa/Carbidopa/Opicapone in Parkinson's Disease Patients. (2022) pubmed
- The efficacy of levodopa/carbidopa/entacapone on cognitive function in moderate to advanced Parkinson's disease and its relationship with peripheral inflammatory cytokines. (2025) pubmed